1.The Curative Effect of Omeprajole Combined with Mosapride in Treatment of Reflux Esophagitis
China Modern Doctor 2009;47(18):126-127
Objective To observe the curative effect that treating and mitigating reflux esophgitis with omeprajoh and mosapride. Methods one hundred and six patients were divided into three groups. The fwst group(36 case) were treated with omeprajole and mosaprid. The second group(35 sides) were treated with omeprajole. The third group(35 sides) were treated with mosapride. The change in symptom and endoscope before and after treatment were observed. Results After treated for two week and four week,the first group was better than second and third group. There was significant difference between first group and second group or third group(P<0.05). When eight week, the symptom had been improved obviously in first group(P< 0.05). Esophageal mucosa erosion was coalesce,the percentage was 86.1%, 62.9%,57.1%, there was significant difference(P < 0.05). Conclusion Omeprazole combined with mosapride is better in curing reflux esophagitis.
2.Incision scar recovery assessment of patients with transaxillary dual-plane breast augmentation assisted with endoscopy
Juan AN ; Huai'an LIN ; Yifan ZHANG ; Jiahua HU ; Yang YU ; Jiaming SUN ; Zhaohao ZHONG ; Danning ZHENG ; Li YU
Chinese Journal of Medical Aesthetics and Cosmetology 2023;29(3):167-170
Objective:To evaluate incision scars of transaxillary breast augmentation by different methods of scar assessment.Methods:A retrospective study was carried out on 30 patients (age range 20 to 50 years, with mean age of 32 years) who underwent endoscopic assisted transaxillary type Ⅰ dual plane breast implant augmentation by a same surgeon from August 2014 to November 2016. Scars were estimated by 3 methods which included Vancouver Scar Scale (VSS), Visual Assessment Scale (VAS) and patients' questionnaire.Results:VAS score for left side scars ranged from 0 to 8 and the median was 1. VAS score for right side scars ranged from 0 to 8.3 and the median was 1. A total of 48 scars were scored in the 0-2 point range, representing 80% of the 60 total. VSS score for left side scars ranged from 0 to 11.6 and the median was 0.8. VSS score for right side scars ranged from 0 to 11.3 and the median was 1.2. A total of 46 scars were scored in the 0-2 point range, representing 76.7% of the total 60 breats. The scores between VSS and VAS had significant statistical differences ( P<0.001). 80.0% of our patients regarded scars as unconspicuous or basically invisible in our questionnaire. Conclusions:The majority of transaxillary incision scars recover in favorable status with high patients satisfactory rate. VAS is a practical tool for evaluating transaxillary incision scars. The VSS score is not equivalent to the VAS score when grading scars only by photos.